The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter, single-arm, open-label phase II study to evaluate the efficacy and safety of YH003 in combination with pembrolizumab and nab-paclitaxel in the first-line treatment of patients with unresectable/metastatic mucosal melanoma.
 
Yu Chen
No Relationships to Disclose
 
Xiaoshi Zhang
No Relationships to Disclose
 
Ya Ding
No Relationships to Disclose
 
Yu Jiang
No Relationships to Disclose
 
Jing Chen
No Relationships to Disclose
 
Xingxiang Pu
No Relationships to Disclose
 
Xiubao Ren
No Relationships to Disclose
 
Weizhen Zhang
No Relationships to Disclose